Literature DB >> 31791981

A case of contrast-induced encephalopathy.

Patrick Neilan1, Daniel Urbine2.   

Abstract

The differential diagnosis of the patient with encephalopathy is broad and remains a common yet challenging problem for critical care physicians. A case is presented of contrast-induced encephalopathy in an 81-year-old man undergoing a left heart catheterisation after receiving iopamidol, a low-osmolar contrast agent. Immediately after receiving contrast, our patient experienced severe headache, agitation, altered mentation and significant skin hypersensitivity. This rare, acute and reversible neurological disturbance can be associated with administration of intra-arterial, osmotic, iodinated contrast. Although uncommon, it is important to recognise the various presentations, risk factors and treatment of this condition. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  adult intensive care; headache (including migraines); intensive care; neurology; neurology (drugs And Medicines)

Mesh:

Substances:

Year:  2019        PMID: 31791981     DOI: 10.1136/bcr-2019-229717

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

1.  Contrast-induced encephalopathy after abdominal CT examination.

Authors:  Raffaella Capasso; Ferdinando Caranci; Renata Conforti; Fabio Oreste Rinaldi; Antonio Pinto
Journal:  Acta Neurol Belg       Date:  2021-04-29       Impact factor: 2.396

2.  Contrast Medium-Induced Encephalopathy After Coronary Angiography- Case Report.

Authors:  Sebastian Andone; Rodica Balasa; Laura Barcutean; Zoltan Bajko; Valentin Ion; Anca Motataianu; Adina Stoian; Smaranda Maier
Journal:  J Crit Care Med (Targu Mures)       Date:  2021-05-12

3.  Contrast-Induced Encephalopathy after Cerebral Angiogram: A Case Series and Review of Literature.

Authors:  Cecelia Allison; Vaibhav Sharma; Jason Park; Clemens M Schirmer; Ramin Zand
Journal:  Case Rep Neurol       Date:  2021-06-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.